CellCura developing unique products that reduce risk and improve efficiency

CellCura AS is a Norwegian company dedicated to the development of novel equipment and products for use in Assisted Reproductive Technology (ART) and Stem Cell Research throughout the world. The core technologies have been created through 15 years of research and products from CellCura will improve safety and efficiency in both clinical and research environments.

Products from CellCura are being developed and validated in association with opinion leaders in these two fields, to ensure they provide real benefits and advances in these critical areas of scientific and medical endeavour.

As these products and enabling technologies become available information will be released to the ART and Stem Cell communities both directly and through this website.

For the latest news from CellCura click on the link below. To receive updates and newsletters electronically please register via our contact form.

Download the latest CellCura brochure

Click here to download the latest CellCura brochure

See CellCura workstations at ESHRE 2009 Amsterdam

Booth number, 46, 47, 74, 75. For more information - www.eshre.com

CellCura changing the way you work

CellCura relocates to Skien

CellCura is pleased to announce it has relocated it’s principal European offices and assembly plant to new premises in Skien south of Oslo. Commenting on the move the CEO, Lesley Hutchins said, "We believe this location close to regional air and ground transportation will ensure we can provide the best possible service to our customers worldwide".

The move to the new premises, which is centrally placed within a new regional biotech cluster development, has been assisted by Skien Næringsfond as and Klosterøyafondet. CellCura is pleased to be one of the companies supporting the ongoing area development and the ecologically sound re-use of former heavy industrial sites. Ms Hutchins further commented that "the new facility has capacity for growth as we anticipate rapidly increasing demand for the CellCura workstations which can be used in both IVF laboratories and research laboratories working with Stem Cells and other cell biology applications."